Bruker Daltonics Introduces New MM2 Advanced Mobile Mass Spectrometer for Chemical Agent Detection and Identification.Business Editors/Health/Medical Writers/High-Tech Writers GOTHENBURG, Sweden--(BUSINESS WIRE)--June 2, 2004 Bruker Daltonics Inc., an operating company operating company A business that engages in transactions with outsiders. of Bruker BioSciences Corporation Bruker Biosciences Corporation is a Massachusetts-based company formed in 2003 which develops and manufactures scientific instrumentation for academic research and industrial use. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : BRKR BRKR Breaker ), announces the MM2(TM), a new mobile mass spectrometer for chemical agent detection and identification. Twenty years TWENTY YEARS. The lapse of twenty years raises a presumption of certain facts, and after such a time, the party against whom the presumption has been raised, will be required to prove a negative to establish his rights. 2. after Bruker pioneered the first mobile mass spectrometer, the MM1, the newly developed MM2 mobile quadrupole A quadrupole is one of a sequence of configurations of electric charge or gravitational mass that can exist in ideal form, but it is usually just part of a multipole expansion of a more complex structure reflecting various orders of complexity. mass spectrometer today is being introduced at the 8th International Symposium on Protection against Chemical and Biological Warfare biological warfare, employment in war of microorganisms to injure or destroy people, animals, or crops; also called germ or bacteriological warfare. Limited attempts have been made in the past to spread disease among the enemy; e.g. Agents in Gothenburg. The MM2 is programmed to measure chemical agents with outstanding sensitivity and exceptional selectivity, allowing positive identification and minimizing false alarms. In a world of changing threats, the MM2 represents the latest development in military-hardened, mobile and light weight GC/MS GC/MS Gas Chromatograph/Mass Spectrometer GC/MS Gas Chromatograph/Mass Spectrometry GC/MS Gas Chromatograph/Mass Spectrograph systems. Its design benefits from more than 20 years of experience in mobile mass spectrometry at Bruker Daltonics. The MM2 is a modern high-performance, yet light weight detection instrument; it utilizes a novel vacuum system allowing significant reductions in size and power consumption. With a volume of just 40 litres, a weight of just 30 kg, as well as further improved sensitivity, the MM2 is the state-of-the-art mass spectrometer for the detection and identification of chemical agents and toxic industrial chemicals in homeland security and defense applications. The MM2 incorporates the latest microcontroller electronics and sophisticated PC-based software to achieve a marked improvement in performance and flexibility. Like its predecessor, the MM2 is extremely rugged, and can be used while in motion and under extreme environmental conditions. The MM2 can be used to measure volatile chemical agents in air, as well as semi-volatile agents that stick to the ground or certain surfaces. Flexible accessories, like a heated membrane surface probe, or a GC with thermal desorption module, allow the use of the system for many important mobile and stationary mission profiles to meet the chemical threats of the post 9/11 world with high reliability. For example, the MM2 is optimized for long-range chemical reconnaissance in various NATO NATO: see North Atlantic Treaty Organization. NATO in full North Atlantic Treaty Organization International military alliance created to defend western Europe against a possible Soviet invasion. armoured vehicles, as well as for mobile chemical agent inspection and detection missions that require positive identification. Mobile mass spectrometry is also the technology of choice for the identification of unknown chemical compounds due to its specificity, especially in combination with gas chromatography. Frank Thibodeau, Business Development Manager for NBC NBC in full National Broadcasting Co. Major U.S. commercial broadcasting company. It was formed in 1926 by RCA Corp., General Electric Co. (GE), and Westinghouse and was the first U.S. company to operate a broadcast network. Detection, said: "The MM1 has been exceptionally successful and over the years has been fielded by various NATO defense and security forces. For instance, in the U.S. Department of Defense alone, more than 100 units are in service. We were thus able to draw upon a wealth of customer experience in developing the long-awaited MM2, and expect that it will be quickly adopted due to its enhanced capabilities and smaller size." ABOUT BRUKER BIOSCIENCES Bruker BioSciences Corporation, headquartered in Billerica, Massachusetts, is the publicly traded parent company of Bruker AXS Inc. and Bruker Daltonics Inc. Bruker AXS is a leading developer and provider of life science and advanced materials research tools based on X-ray technology. Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry. Bruker Daltonics also offers a broad line of nuclear, biological and chemical detection products for defense and homeland security. For more information, please visit www.bruker-biosciences.com. CAUTIONARY STATEMENT Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's reorganization strategies, integration risks, failure of conditions, technological approaches, product development, market acceptance, cost and pricing of the Company's products, changes in governmental regulations, capital spending and government funding policies, FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. and other regulatory approvals to the extent applicable, competition, the intellectual property of others, patent protection and litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. . These and other factors are identified and described in more detail in our filings with the SEC, including, without limitation, our annual report on Form 10-K for the year ended December 31, 2003, our most recent quarterly reports on Form 10-Q and our current reports on Form 8-K. We disclaim any intent or obligation to update these forward-looking statements. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion